Aida Varghaei
1 
, Hengameh Mojdeganlou
2 , Masomeh Rabieepour
3 , Amir Mikaeilvand
4 , Ata Abbasi
5,2* 1 Department of Dermatology, Faculty of Medicine, Urmia University of Medical Sciences, Urmia, Iran
2 Department of Pathology, Faculty of Medicine, Urmia University of Medical Sciences, Urmia, Iran
3 Department of Internal Medicine, Faculty of Medicine, Urmia University of Medical Sciences, Urmia, Iran
4 Department of Cardiology, Faculty of Medicine, Urmia University of Medical Science, Urmia, Iran
5 Cellular and Molecular Research Center, Cellular and Molecular Medicine Institute, Urmia University of Medical Sciences, Urmia, Iran
Abstract
Interstitial lung disease (ILD) is a common manifestation of dermatomyositis (DM) with indolent course but a unique variant of DM called clinically amyopathic DM (CADM) presents with rapid progressive ILD (RP-ILD) and is called CADM associated RP-ILD. Here, we report a case of a 52-year-old woman with CADM associated RP-ILD occurred 2 weeks after recovery from COVID-19 infection but unfortunately died from RP-ILD, almost 5 months later. This is the first report of CADM associated RP-ILD triggered by COVID-19 in an adult patient.
Keywords: Dermatomyositis, Interstitial lung disease, COVID-19